High prevalence of thyroid abnormalities in a Chilean psychiatric outpatient population

Journal of Endocrinological Investigation

Volumn 23, Issue 2, 2000, Pages 102-106

  Fardella, Carlos E ^a   Gloger, S ^b   Figueroa, R ^a   Santis, R ^a   Gajardo, C ^b   Salgado, C ^b   Barroilhet, S ^a   Foradori, A ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Centro NeuroPsiquiatrico de Santiago   (Chile)

Author keywords

Mood disorders; Panic disorder; Prevalence; Thyroid

Indexed keywords

MICROSOME ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CHILE; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PANIC; PSYCHIATRIC DEPARTMENT; THYROID DISEASE;

EID: 0034124356     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343687     Document Type: Article

References (37)

1. Larsen P.R., Ingbar S.H. The thyroid gland. In: Wilson J.D., Foster D.W. (Eds.), Williams textbook of Endocrinology, ed. 8. W.B. Saunders Company, Philadelphia, 1992, p. 358.
2. Lishman WA Endocrine diseases and metabolic disorders. In: Lishman W.A. (Ed.), Organic Psychiatry. The psychological consequences of cerebral disorder, ed. 2. Blackwell Scientific Publication, Oxford, 1987, p. 428.
3. Prange A.J., Haggerty J.J., Browne J.L., Rice J.D. Marginal hypothyroidism in mental illness: Preliminary assessments of prevalence and significance. In: Bunney W.E.Jr., Hippius H., Laakmann G., Schmauss M. (Eds.), Neuropsychopharmacology. Springer Berlin, 1990, p. 352.
4. Gold M.S., Pottash A.L.C., Extein I. Hypothyroidism and depression: evidence from complete thyroid function evaluation. J. Am. Med. Assoc. 1981, 245: 1919-1922.
5. Talli F. Primary hypothyroidism: a case for vigilance in the psychological treatment of depression. Br. J. Clin. Psychol. 1993, 32: 261-270.
6. Fava M., Labbate L.A., Abraham M.E., Rosenbaum J.F. Hypothyroidism and hyperthyroidism in major depression revisited. J. Clin. Psychiatry 1995, 56: 186-192.
7. Morley J.E., Shafer R.B. Thyroid function screening in new psychiatric admissions. Arch. Intern. Med. 1982, 142: 591-593.
8. Bannister P., Mortimer A., Shapiro L, Simms A.C.P. Thyroid function screening of psychiatric inpatients admissions: A worthwhile procedure? J. Royal Soc. Med. 1987, 80: 77-78.
9. Oppenheimer J.H., Braveman L.E., Toft A., Jackson I., Ladenson P.W. A therapeutic controversy. Thyroid hormone treatment: When and what? J. Clin. Endocrinol. Metab. 1995, 80: 2873-2883.
10. Gewirtz G.R., Malaspina D., Hatterer J.A., Feureisen S, Klein D., Gorman J.M. Occult thyroid dysfunction in patients with refractory depression. Am. J. Psychiatry 1988, 145: 1012-1014.
11. Jackson I.M. Does thyroid hormone have a role as adjunctive therapy in depression? Thyroid 1996, 6: 63-67.
12. Kirkegaard C., Faber J. The role of thyroid hormones in depression. Eur. J. Endocrinol. 1998, 138: 1-9.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, ed. 4. American Psychiatric Association, Washington D.C., 1994.
14. Dudley R.F. The Ciba Corning ACS: 180 Automated Immunoassay System. J. Clin. Immunoassay 1991, 14: 77-82.
15. Fisher D.A. Physiological variations in thyroid hormones: physiological and pathophysiological considerations. Clin.Chem. 1996, 42: 135-139.
16. Kultkovski M., Long L., Beery G., Seery J., Blake D., Travis K. Communication 0589. XIV International Congress of Clinical Chemistry. San Francisco, California, USA, July 22-26 1990.
17. Hickie I., Bennett B., Mitchell P., Wilhelm K., Orlay W. Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Aust. N.Z.J. Psychiatry 1996, 30: 246-252.
18. Howland R.H. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J. Clin. Psychiatry 1993, 54: 47-54.
19. Gloger S., Fardella C., Santis R., Bitran J. Relevancia del estudio tiroideo en pacientes con trastornos psiquiatricos. Rev. Med. Chil. 1997, 125: 1351-1356.
20. Woolf P.D., Nichols D., Porsteinsson A., Boulay R. Thyroid evaluation of Hospitalized Psychiatric Patients: The Role of TSH Screening for Thyroid Dysfunction. Thyroid 1996, 6:451-456.
21. Figueroa R., Gloger S., Montero J., Alvarez C., Velasquez C.G., Foradori A., Gajardo C., Salgado C., Fardella C. Prevalence of thyroid abnormalities in normal population. [Abstracts]. XI Chilean Congress of Endocrinology 1998: 31.
22. Wiersinga W.M. Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. Neth. J. Med. 1995, 46: 197-204.
23. Bilous R.W., Tunbridge W.M. The epidemiology of hypothyroidism an update. Baillieres Clin. Endocrinol. Metab. 1988, 2: 531-540.
24. Tunbridge W.M., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Evans J.G., Young E., Bird T., Smith P.A. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf.) 1977, 7: 481-493.
25. Woeber K.A. Subclinical thyroid dysfunction. Arch. Intern. Med. 1997, 157: 1065-1068.
26. Konno N., Yuri K., Taguchi H., Miura K., Taguchi S., Hagiwara K., Murakami S. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin. Endocrinol. (Oxf.) 1993, 38: 273-281.
27. Okamura K., Nakashima T., Ueda K., Inoue K., Omae T., Fujishima M. Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences. Int. J. Epidemiol. 1987, 16: 545-549.
28. Vanderpump P.J., Tunbridge W.M.G. The epidemiology of thyroid disease. In: Braverman LE., Utiger R.D. (Eds.), The Thyroid, ed. 7. Lippincott-Raven, Philadelphia, New York, 1996, p. 477.
29. Kung A.W. Life events, daily stresses and coping in patients with Graves Disease. Clin. Endocrinol. (Oxf.) 1995, 42: 303-308.
30. Radosavljevic V.R., Jankovic S.M., Marinkovic J.M. Stressful life events in the pathogenesis of Graves disease. Eur. J. Endocrinol. 1996, 134: 699-701.
31. Harris T., Creed F., Brugha T.S. Stressful life events and Graves disease. Br. J. Psychiatry 1992, 161: 535-541.
32. Winsa B., Adami H.-O., Bergstrom R., Gamstedt A., Dahlberg D.A., Adamson U., Jansson R., Karlsson A. Stressful life events and Graves disease. Lancet 1991, 338: 1475-1479.
33. Muzzo S., Burgueño M., Carvajal F., Biolley E., Avendaño M., Vargas A., Leiva L. Nutrición de yodo en escolares de cuatro zonas censorias de Chile. Rev. Med. Chil. 1997, 125: 1299-1304.
34. Benmiloud M., Chaouki M.L., Gutekunst R., Teichert H., Wood W.G., Dunn J.T. Oral iodized oil for correcting iodine deficiency: Optimal dosing and outcome indicator selection. J. Clin. Endocrinol. Metab. 1994, 79: 20-24.
35. Michaud P., Téllez R. Función tiroidea en una población con aporte extra de yodo. Rev. Med. Chil. 1998, 126: 177-182.
36. Geul K.W., van Sluisveld I.L.L., Grobbee D.E., Docter R., de Bruyn A.M., Hooykaas H., van der Merwe J.P., van Hemert A.M., Krenning E.P., Hennemann, Weber F.A. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clin. Endocrinol. (Oxf.) 1993, 39: 275-280.
37. Vanderpump M.P.J., Tunbridge W.M.G., French J.M., Appleton D., Bates D., Clark F., Grimley Evans J., Rodgers H., Tunbridge F., Young E.T. The incidence of thyroid disorders in the community: a twenty years follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 1995, 43: 55-68.